Form 8-K REPLIGEN CORP For: Aug 04

Go back to Form 8-K REPLIGEN CORP For: Aug 04

Repligen (RGEN) Tops Q2 EPS by 3c

August 4, 2016 7:54 AM EDT

Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $29.2 million versus the consensus estimate of $24.75 million.

GUIDANCE:

Repligen sees FY2016 EPS of $0.42-$0.48, versus the consensus of $0.47. Repligen sees... More